Heart Disease is the #1 killer of women.
Most never see it coming.
Woman
Nearly 80% of cardiovascular disease is preventable. Yet the majority of women aren't screened to identify potential risks - such as the presence of breast arterial calcification. Mammo+Heart changes that.
Find a Participating Center 

How breast arterial calcification impacts your health

0%
Increase in risk of heart disease or stroke1
0x
Increase in cardiovascular
event-specific death2
0%
women aged 60-79 that
have arterial calcification3
0%
of all women4

Mammo+Heart AI screening software* can detect breast arterial calcification when used in parallel with screening mammography.

1 American Heart Association - Mammograms may provide clues about women's risk for cardiovascular disease - Accessed May 15, 2025.   2 National Library of Medicine - Relationship between arterial calcification on mammograms and cardiovascular events - Accessed May 15, 2025.   3 National Library of Medicine - Relationship between arterial calcification on mammograms and cardiovascular events - Accessed May 15, 2025.   4 Journal of Breast Imaging - Patient notification about breast arterial calcification on mammography - Accessed May 15, 2025.

Mammo+Heart logo 

Now your mammogram can give you insight into both your breast and heart health.

Breast arterial calcification is a calcium build up in the arteries of the breast. As calcium deposits form, the vessel wall becomes stiffer and less elastic and can lead to increased pressure on the heart as it works to pump blood through the vessels. The presence of calcified arteries in the breast has been linked to an increased risk for cardiovascular disease in women, as indicated in a 2019 article in Circulation, a journal for the American Heart Association, and according to a November 2024 article in s JACC: Advances.

HSA Eligible
FSA Eligible
Relaxed woman on couch

REAL CHOICES. REAL INSIGHT. REAL PEACE OF MIND.

“I've told my sisters & my friends. It's an amazing health checkup!”
“It was a good idea to do the Mammo+Heart, in order to find any problems early. I have a family history of heart problems, so it was worth the extra money.”
“I thought it would be a good idea since heart disease runs in my family. I was surprised it was offered at the same time as my mammogram!”
“I am very proactive with my health needs and I chose the Mammo+Heart screening for peace of mind. I love the integration of AI.”
 

Your mammogram can do more when paired with Mammo+Heart

Breast arterial calcification is a finding that is present on mammograms and can be an indicator of heart disease. Mammo+Heart uses advanced AI technology that detects this finding and identifies it 44% more often than radiologists alone. Simply opt in at your next mammogram.

 

Dr. Chirag Parghi video 

Watch the video

What is Mammo+Heart?

Listen to our own Chief Medical Officer, Dr. Chirag Parghi, explain what Mammo+Heart is, and how you could benefit.

Frequently Asked Questions

Mammo+Heart is an AI screening tool for asymptomatic women between the ages of 40 and 89*. It is intended to detect the presence or absence of breast arterial calcification in parallel with breast screening mammography. It is not intended to be a diagnostic test; however it is an indication of possible cardiovascular risk and may require patient action, according to a JACC: Cardiovascular Imaging article published in 2016, which is cited here:
https://www.sciencedirect.com/science/article/pii/S1936878X16000164?via%3Dihub
*In the Philadelphia market, Mammo+Heart is recommended for asymptomatic women between the ages of 40 and 79.

Currently, patients with breast implants are not eligible for Mammo+Heart.

Let the front desk know at check-in. Online opt-in is not yet available.

Yes, the breast arterial calcification detection and localization software that Solis Mammography uses is FDA cleared.

There is “strong evidence for an association between BAC (breast arterial calcification) and coronary artery disease, heart failure, stroke, peripheral arterial disease, and increased risk of cardiovascular death,” as reported in the Journal of Breast Imaging, cited here: https://doi.org/10.1093/jbi/wbad063. Patients with this finding may be candidates for additional cardiovascular screening by their primary care physician or cardiologist.

Mammo+Heart AI software reads mammography images to help the interpreting radiologist determine the presence or absence of breast arterial calcification. An expert radiologist will review and sign off on these results.

Yes, multiple clinical studies have found significant correlation between the presence of breast arterial calcification and cardiovascular disease. One such study noted that women who had breast arterial calcification present on their mammogram were 51% more likely to develop heart disease or have a stroke compared with women who did not have breast arterial calcification. https://newsroom.heart.org/news/mammograms-may-provide-clues-about-womens-risk-for-cardiovascular-disease

Another study on the relationship between breast arterial calcifications on mammograms and cardiovascular events stated that cardiovascular mortality increased by 40% in women with breast arterial calcification compared to women without it, reaching 90% in diabetic women. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776346/

Your breast arterial calcification results will be delivered via secure email, typically within a few business days.

If you are an Avestee patient in the San Antonio area, you will receive an email notifying you that your results are available in your patient portal, typically within 2-3 business days. Patients without portal access will receive their results via email.

We recommend that you consult with your primary care physician to determine if further cardiac evaluation is appropriate after receiving your Mammo+Heart screening result.

The absence of breast arterial calcification is not a final diagnosis relating to the absence of coronary heart disease. The presence of other signs or symptoms should be discussed with your primary care physician. We recommend that you consult with your primary care physician to determine if further cardiac evaluation is appropriate after receiving your Mammo+Heart screening result.

See the following citations for more clinical insight into breast arterial calcification and its association with cardiovascular risk.


 

Mammo+Heart Centers

Mammo+Heart uses cmAngio®, an FDA-Cleared Artificial Intelligence (AI) based detection software, to identify the presence or absence of breast arterial calcification (BAC) as an incidental finding in FFDM and DBT screening mammograms, where standard views are utilized. The cmAngio® software is not cleared by the FDA for use in connection with screening mammograms where displacement or alternative views are utilized; therefore, Mammo+Heart is not available to patients who require alternative views for their screening mammogram. The BAC finding indicates whether calcium buildup is present in the breast arterial wall. BAC has been associated with a higher risk of coronary heart or cardiovascular disease, but the presence or absence of BAC alone is not a diagnosis for coronary heart or cardiovascular disease or determinative of a patient’s risk for coronary heart or cardiovascular disease. Results from Mammo+Heart may be used for further patient management at the discretion of a primary care physician, cardiologist, or specialist. If BAC is detected, please consult your primary care physician, a cardiologist, or specialist for further information on diagnosis and treatment.